Biotech Values

[drbio45]

Rbm has more upside than camh

I was at a meeting with the ceo of Standard Diagnostics (SDIX).

Believing that he would probably know the diagnostics industry pretty well I asked him a question about the money being spent on Biosite and the bidding war between Beckman Coulter and Inverness. The analysts are all saying that the companies want Biosite's distribution so that is the way I asked the following question.

I asked him if the reason that the companies want Biosite so badly was because they wanted Biosite's distribution? He said the only reason they wanted Biosite was because they wanted to own the rapid BNP and cardiovascular market.

Lumpy, you have been following Response Biomedical and you are aware that RBM's data puts Biosite's to shame. What will Response be worth when they will have the preferred test?